trial
as of 2026-07-01Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
NCTId NCT00158223
at a glance
Phase 4 · Completed
Enrollment 76 (actual)
Sponsored by Icahn School of Medicine at Mount Sinai
Primary completion 2009-02
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
76 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2004-10
Primary completion
2009-02
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Icahn School of Medicine at Mount SinaiLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
Investigators
1
Joseph I. Friedman, MDPrincipal Investigator
Sites
3 total
New York, United StatesNew York, United StatesW. Brentwood, United States
Facts & assertions
4 sourced
Enrollment
76
Phase
PHASE4
Primary Completion Date
2009-02
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person